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Background: Patients with ACS often present to community hospitals without on-site cardiac catheterization and
revascularization therapies. Transfer to specialized cardiac procedural centers is necessary to provide access to these
procedures. We evaluated process of care within a regional care model by comparing cardiac catheterization and
revascularization rates and outcomes in ACS patients presenting to community and interventional hospitals.
Methods: We evaluated a total of 6154 patients with ACS admitted to Southern Alberta hospitals (where a distinct
regional care model for ACS exists) between January 1, 2005 and December 31, 2009. We compared cardiac
catheterization and revascularization rates during index hospitalization among patients admitted to community and
interventional hospitals. Thirty day and 1-year survival were also evaluated.
Results: Catheterization was performed more often in patients presenting to community hospitals compared to the
interventional facility (respectively 69.5% and 51.4%, p < 0.0001). Catheterization within 72 hours of admission
occurred in 48% of patients presenting to the interventional center and in 68.3% of community patients (P < 0.0001). In
patients undergoing catheterization, revascularization (PCI and/or CABG) was also performed more frequently in the
community group (74.5% vs 56.1%, P < 0.0001). Risk adjusted mortality rates were the same for patients undergoing
cardiac catheterization regardless of hospital of initial presentation.
Conclusion: ACS patients presenting to community centers associated with a regional care model had effective access
to cardiac catheterization and revascularization. These findings support the importance of regional initiatives and
processes of care that facilitate access to cardiac catheterization for all ACS patients.
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Acute coronary syndromes (ACS) represent a common
cause for hospital admissions and mortality in patients
with cardiovascular disease. In patients with non-ST ele-
vation myocardial infarction (NSTEMI), an early invasive
strategy, in patients without contraindications or pro-
hibitive comorbidities, is superior to a selective invasive
strategy in reducing rehospitalization and myocardial* Correspondence: mmg2@ualberta.ca
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unless otherwise stated.infarction (MI) [1,2]. Indeed, guidelines endorse an early
invasive strategy defined as cardiac catheterization and
revascularization within 48–72 hours of presentation for
high-risk patients [3-6]. However, patients with ACS
usually present to the nearest acute care facilities for
evaluation and management. These are often community
hospitals that lack cardiac catheterization and revascu-
larization (percutaneous coronary intervention [PCI]
and coronary artery bypass grafting [CABG]) abilities.
Efficient inter-hospital transfer between community and
tertiary centers is therefore necessary to provide access to
these procedures. Previous studies have demonstrated that
a significant number of ACS patients in the communityLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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for invasive management [7-9].
We have developed a large, population-based clinical
registry that captures all patients undergoing cardiac
catheterization and revascularization in Alberta, Canada
since 1995. The subsequent expansion of this registry to
include all cardiac admissions in Southern Alberta pro-
vides a unique opportunity to examine practice patterns
(such as transfer for cardiac catheterization) and out-
comes in unselected ACS patients. The purpose of this
study was to evaluate process of care within a regional
care model by comparing cardiac catheterization and re-
vascularization rates and outcomes in ACS patients pre-
senting to community and interventional hospitals.
Methods
All data were derived from the Alberta Provincial Program
for Outcome Assessment in Coronary Heart disease
(APPROACH). APPROACH is an ongoing prospective
cohort study of all Alberta residents undergoing cardiac
catheterization for coronary artery disease since 1995,
which expanded in 2004 to include cardiac admissions
in Southern Alberta. The initiative has been previously de-
scribed [10]. In brief, this population-based, multiple-year
inception cohort database contains detailed information
on socio-demographic characteristics, presence of risk fac-
tors and comorbidities, disease-specific variables, coronary
catheterization results, post-catheterization referral deci-
sions, records of actual revascularization and long-term
outcomes including survival and quality of life. Data from
APPROACH are routinely enhanced by merging the clin-
ical registry data to administrative records to supplement
clinical information available on all patients. This data en-
hancement methodology has been validated and previ-
ously reported [11]. Patient survival from catheterization
and/or revascularization until death is ascertained
through semi-annual linkage to Alberta Vital Statistics
records. The APPROACH registry has an approved
privacy impact assessment. The University of Calgary
and University of Alberta Research Ethics Boards have
approved APPROACH registry data collection and link-
ages with secondary sources.
For the present study we identified all patients over
the age of 18 with ACS (NSTEMI and unstable angina
(UA)) admitted to hospitals in Southern Alberta. This
region is a large geographic area of over 1.6 million
people served by one interventional center in the city of
Calgary with a constellation of smaller community hos-
pitals in surrounding areas. This Calgary Health Region
is one of the largest, fully integrated health care systems
in Canada.
Patients were categorized according to location and
facilities available in the hospital of initial admission:
1) community hospitals: comprised of secondary referralcenters staffed by specialists and/or general practitioners
and smaller primary centers without on-site specialty
physicians. All community centers lack on-site cardiac
catheterization facilities and are located a minimum of
49 kilometers (km) and a maximum of 291 km (average
220 km) from the interventional center, 2) interven-
tional hospital: the only tertiary care center with on-site
cardiac catheterization and revascularization abilities
and cardiology specialists. Each rural region has inde-
pendent ACS management protocols, however, when a
patient requiring cardiac catheterization is identified, re-
ferring physicians complete a standard referral form that
is sent to the catheterization center by fax, along with rele-
vant history, GRACE score, laboratory data, and other
tests if applicable. When the referral is complete, it is
reviewed by a member of the interventional cardiology
group for approval and triage for urgency and arrange-
ments for transport to the interventional center are made.
Statistical analysis
The primary outcomes of interest were cardiac
catheterization and revascularization rates during index
admission among patients admitted to community ver-
sus interventional hospitals. Baseline comparisons of
clinical characteristics between patient groups were
made by the Chi Square Test for categorical variables
and by ANOVA for continuous variables. Kaplan-Meier
analysis was used to present the unadjusted thirty-day and
one-year survival rates from the index hospitalization for
each patient group. Cox proportional hazard models were
then used to calculate survival following risk adjustment
for the clinical characteristics and comorbidities presented
in Table 1. All analyses were conducted using SAS 9.2,
(Cary, North Carolina).
Results
Our cohort consisted of 6154 ACS patients admitted to
hospitals in Southern Alberta between January 1, 2005
and December 31, 2009. Of these patients, 2592 (42.1%)
were admitted initially to community hospitals and 3562
(57.9%) to the interventional center. Baseline patient
characteristics were analyzed according to type of admit-
ting hospital (Table 1) and cardiac catheterization status
(Table 2). Smoking, dyslipidemia, previous heart failure,
initial diagnosis of NSTEMI and the presence of dynamic
electrocardiogram changes were all more prevalent in pa-
tients admitted to community hospitals. Patients admitted
to the interventional hospital more commonly had a his-
tory of previous revascularization (PCI /CABG) and were
more likely to be on dialysis than those admitted to com-
munity hospitals.
Figure 1 depicts cardiac catheterization and revascu-
larization rates according to type of admitting hospital.
Catheterization was performed more frequently in
Table 1 Baseline characteristics
Characteristic Interventional N =3562 Community N =2592 p value
Age (years) 66.4 ± 12.6 66.3 ± 13.0 0.84
Male 2474 (69.5%) 1768 (68.2%) 0.31
Diabetes 872 (24.5%) 678 (26.2%) 0.14
Hypertension 2357 (66.2%) 1732 (66.8%) 0.59
Dyslipidemia 2636 (74.0%) 1999 (77.1%) 0.005
Smoker 675 (19.0%) 660 (25.5%) <0.0001
Previous MI 959 (26.9%) 677 (26.2%) 0.50
Previous PCI 880 (24.7%) 484 (18.7%) <0.0001
Previous CABG 413 (11.6%) 227 (8.8%) 0.0003
Previous heart failure 252 (7.1%) 238 (9.2%) 0.003
Chronic renal failure 115 (3.2%) 74 (2.9%) 0.40
Acute renal failure 10 (0.3%) 10 (0.4%) 0.48
Dialysis 76 (2.1%) 29 (1.1%) 0.002
Cerebrovascular disease 292 (8.2%) 196 (7.6%) 0.36
Peripheral vascular disease 172 (4.8%) 137 (5.2%) 0.46
Mean heart rate (beats/min) 75.5 (19.3) 76.5 (20.2) 0.05
Mean systolic BP (mmHg) 138.8 (25.7) 142.1 (27.4) <0.0001
Mean diastolic BP (mmHg) 77.8 (16.2) 80.2 (17.4) <0.0001
Systolic BP < 100 136 (3.9%) 106 (4.2%) 0.63
Presence of shock 32 (0.9%) 18 (0.7%) 0.38
ECG dynamic changes 419 (11.8%) 437 (16.9%) <0.0001
Presentation diagnosis <0.0001
Unstable angina 2286 (42.5) 1334 (33.7)
NSTEMI 1276 (23.7) 1259 (31.7)
Non-invasive tests† performed within 3 months prior to admission 471 (13.2%) 288 (11.1%) 0.013
Catheterization not received 1730 (48.6%) 1834 (32.2%) <0.0001
Catheterization received 11832 (51.4%) 1759 (67.8%)
Within 24 hours of admission 594 (16.7%) 255 (9.8%) <0.0001
Within 48 hours of admission 995 (54.3%) 571 (32.5%) <0.0001
Within 72 hours of admission 1260 (68.8%) 844 (48%) <0.0001
Values are expressed as mean ± SD and number (%).
MI =Myocardial infarction, PCI = Percutaneous coronary intervention, CABG = Coronary artery bypass grafting, BP = Blood pressure, ECG = Electrocardiogram,
mmHg =Millimeters of mercury, NSTEMI = Non-ST elevation myocardial infarction.
†Non-invasive tests includes nuclear thallium, stress ECHO, treadmill, CT, MRI and peripheral angiography.
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those admitted initially to the interventional facility
(respectively 69.5% and 51.4%, p < 0.0001). In patients
undergoing catheterization, revascularization (PCI and/
or CABG) was also performed more frequently in the
community group compared to the interventional group
(respectively, 74.5% and 56.1%, P < 0.0001). The overall
mean time to cardiac catheterization was 3.2 days. Pa-
tients admitted to the interventional center underwent
catheterization sooner than those admitted to commu-
nity centers (2.6 vs. 4 days, p < 0.001). In the interventional
group, 9.8% underwent catheterization within 24 hours of
admission compared to 16.7% in the community group.Within 48 hours from admission, 32.5% and 54.3% of
the interventional and community patients underwent
catheterization and within 72 hours, 48% and 68.3%
had undergone the procedure (p < 0.0001).
Figure 2 demonstrates Kaplan Meier survival curves
extending to one year of follow up. There was an early
separation of the curves that persisted with longer
follow-up, with crude mortality rates significantly lower
in patients undergoing cardiac catheterization in both
community (12.7% vs. 3.5%) and interventional (9.1% vs.
4.2%) centers p < 0.0001. Survival was lower for patients
not referred for catheterization from an admitting com-
munity hospital compared to patients first admitted to












Age (years) 68.1 (13.2) 64.8 (11.9) <0.0001 69.6 (14.6) 64.9 (12.0) <0.0001 <0.0001
Male 1,147 (66.3%) 1,327 (72.4%) <0.0001 472 (59.7%) 1,296 (72.0%) <0.0001 <0.0001
Diabetes 441 (25.5%) 431 (23.5%) 0.173 216 (27.3%) 462 (25.7%) 0.377 0.18
Hypertension 1,157 (66.9%) 1,200 (65.5%) 0.386 511 (64.6%) 1,221 (67.8%) 0.112 0.32
Dyslipidemia 1,227 (70.9%) 1,409 (76.9%) <0.0001 513 (64.9%) 1,486 (82.5%) <0.0001 <0.0001
Smoker 310 (17.9%) 365 (19.9%) 0.127 157 (19.9%) 503 (27.9%) <0.0001 <0.0001
Previous MI 496 (28.7%) 463 (25.3%) 0.022 246 (31.1%) 431 (23.9%) 0.0001 0.0002
Previous PCI 449 (26.0%) 431 (25.3%) 0.093 140 (17.7%) 344 (19.1%) 0.399 <0.0001
Previous CABG 235 (13.6%) 178 (9.7%) 0.0003 91 (11.5%) 136 (7.6%) 0.001 <0.0001
Previous heart failure 162 (9.4%) 90 (4.9%) <0.0001 123 (15.6%) 115 (6.4%) <0.0001 <0.0001
Chronic renal failure 66 (3.8%) 49 (2.7%) 0.054 27 (3.4%) 47 (2.6%) 0.258 0.12
Acute renal failure 7 (0.4%) 3 (0.2%) 0.175 8 (1.0%) 2 (0.1%) 0.0007 0.001
Dialysis 43 (2.5%) 33 (1.8%) 0.158 10 (1.3%) 19 (1.1%) 0.641 0.008
Cerebrovascular disease 149 (8.6%) 143 (7.8%) 0.380 79 (10.0%) 117 (6.5%) 0.002 0.013
Peripheral vascular disease 89 (5.1%) 83 (4.5%) 0.393 53 (6.7%) 83 (4.6%) 0.028 0.097
Mean heart rate (beats/min) 74.6 (19.8) 76.3 (18.9) 0.012 79.2 (20.6) 75.4 (20.0) <0.0001 <0.0001
Mean systolic BP (mmHg) 136.8 (25.7) 140.7 (25.6) <0.0001 140.7 (27.8) 142.7 (27.2) 0.092 <0.0001
Mean diastolic BP (mmHg) 75.7 (15.9) 79.8 (16.2) <0.0001 78.0 (17.0) 81.2 (17.5) <0.0001 <0.0001
Systolic BP < 100 78 (4.7) 58 (3.2) 0.029 39 (5.1) 67 (3.8) 0.142 0.068
Presence of shock 13 (0.8%) 19 (1.0%) 0.367 9 (1.1%) 9 (0.5%) 0.072 0.22
ECG dynamic changes 189 (10.9%) 230 (12.6%) 0.131 138 (17.5%) 299 (16.6%) 0.597 <0.0001
Presentation diagnosis <0.0001 <0.0001 <0.0001
Unstable angina 523 (30.2%) 753 (41.1%) 306 (38.7%) 953 (52.9%)
NSTEMI 1,207 (69.8%) 1,079 (58.9%) 485 (61.3%) 848 (47.1%)
Non-invasive tests† performed
within 3 month prior to admission
360 (20.8%) 256 (14.0%) <0.0001 100 (12.6%) 248 (13.8%) 0.438 <0.0001
Values are expressed as mean ± SD and number (%).
MI =Myocardial infarction, PCI = Percutaneous coronary intervention, CABG = Coronary artery bypass grafting, BP = Blood pressure, ECG = Electrocardiogram, mmHg
=Millimeters of mercury, NSTEMI = Non-ST elevation myocardial infarction.
†Non-invasive tests includes nuclear thallium, stress ECHO, treadmill, CT, MRI and peripheral angiography.
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catheterization (87.3% vs. 90.9%, p = 0.003).
Table 3 demonstrates crude and adjusted hazard ratios
for our cohort. After adjusting for baseline risk factor
characteristics seen in Table 1, no difference in outcome
at 30 days or 1 year was noted between those admitted
to the interventional center and those initially admitted
to community centers.
Discussion
This analysis from a large cohort of geographically di-
verse patients indicates that regionalization of tertiary
ACS services enables access to cardiac catheterization
for patients from community centers. Indeed, within this
regional care model, patients presenting initially to com-
munity hospitals actually had higher rates of cardiaccatheterization and revascularization than those present-
ing initially to the interventional center, and underwent
these procedures in a timely fashion.
The advantages of regional care centers for the treat-
ment of ST elevation myocardial infarction (STEMI)
have been clearly described [12-14]. Regional approaches
to STEMI care focus on rapid identification and early re-
perfusion therapy with the goal of reducing morbidity
and mortality. The essential components of regional
STEMI care plans include detailed treatment and trans-
fer protocols, community planning, resources, education,
quality improvement analysis and research [15]. Likewise,
the development of regionalized comprehensive stroke
centers for the care of patients with acute stroke has ad-
dressed disparities in the delivery of stroke services par-
ticularly between urban and rural centers [16-18].
Figure 1 Cardiac catheterization and revascularization rates by
presenting hospital (Revascularization defined as percutaneous
coronary intervention or coronary artery bypass grafting).
Catheterization: Int 1,832 (51.4%) vs. comm 1,801 (69.5%), P<0.0001.
Revascularization: Int 1,027 (56.1%) vs. comm 1,342 (74.5%), P<0.0.
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for patients with NSTEMI, particularly in the geograph-
ically robust provinces of Canada. The Heart Protection
Partnership (HPP) project was an Australian initiative
developed to audit compliance with evidence-based
treatments in patients with acute coronary syndromes
treated at interventional and non-interventional centers
across the country. The program identified treatment
gaps, particularly in non-interventional centers, and pro-
vided feedback to individual centers with the purpose of
improving compliance with benchmark standards of care
[19]. Ideally, regional centers for ACS should provide
effective and efficient care for patients by improving ac-
cess to cardiac catheterization, revascularization, special-
ist physicians and to new technologies or medications
not available at other centers. The regional care modelFigure 2 Kaplan Meier plot demonstrating survival from admission w
status (C = community hospitals, M =metropolitan hospitals, I = intervwithin Southern Alberta consists of one PCI capable cen-
ter that provides specialized procedural cardiac care to nu-
merous smaller and geographically distant community
centers. This model’s process of care involves a well estab-
lished referral system for cardiac catheterization whereby
direct communication between community and subspe-
cialty physicians, delivery of detailed patient information
and efficient risk based triage of community ACS patients
translates into timely referral for and access to cardiac
catheterization.
Geographic disparity in cardiac catheterization and re-
vascularization rates in ACS are well described. A large
registry study in Denmark found higher coronary angi-
ography and revascularization rates in ACS patients res-
iding close to an interventional facility compared to
those residing at a further distance, with a higher prob-
ability of receiving catheterization and revascularization
if admitted directly to an interventional center [8].
The Dartmouth Atlas of Cardiovascular Health Care
in the United States recognized that rates of cardiac
catheterization varied substantially from the national
average in many referral regions [20]. Another group
of investigators from the United States demonstrated
that less than half of patients presenting to community
hospitals with ACS were transferred to tertiary hospitals
for cardiac catheterization [9]. This geographical variance
has also been described in Canada where investigators in
the province of Nova Scotia found lower rates of cardiac
catheterization for patients residing outside of a metropol-
itan area [21]. Data from the New Zealand Cardiac Society
Audit Group demonstrated that patients with ACS admit-
ted to non-interventional centers were less likely to be re-
ferred and had longer time delays to access cardiac
catheterization compared to those admitted to interven-
tional centers [22]. In our study we found that despite largeith acute coronary syndrome stratified by cardiac catheterization
entional hospital, cath = cardiac catheterization).
Table 3 Hazard ratios for 30-day and 1-year mortality








Cath Interventional Reference Reference Reference Reference
Cath Community 1.16 (0.65, 2.05) 1.04 (0.58, 1.85) 0.84 (0.60, 1.18) 0.79 (0.56, 1.11)
No Cath Interventional 2.58 (1.57, 4.24) 2.38 (1.43, 3.97) 2.23 (1.69, 2.93) 2.05 (1.55, 2.72)
No Cath Community 3.86 (2.27, 6.56) 2.31 (1.32, 4.06) 3.15 (2.33, 4.26) 2.06 (1.50, 2.84)
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presenting to community hospitals had similar or even
greater access to cardiac catheterization compared to those
initially presenting to the interventional facility.
Randomized controlled trials and meta-analyses have
demonstrated better clinical outcomes in NSTEMI pa-
tients treated with an early invasive approach (early car-
diac catheterization and revascularization as required for
moderate to high risk NSTEMI) [22-26]. These studies
showed a consistent reduction in recurrent ischemia and
re-infarction but inconsistencies in the survival benefit.
In our study we found better 30-day and 1-year out-
comes in patients managed invasively compared to those
managed conservatively. Due to the observational nature
of this study, selection bias may influence outcomes and
partially account for baseline differences in patients chosen
for cardiac catheterization. This limits generalization of
our findings to different populations. Further evaluation of
detailed patient characteristics and comorbidities, patient
preferences, the shared decision-making process and po-
tential referral physician selection bias are necessary to ex-
plain these findings.
In this study, there were no differences in 30-day or 1-
year risk adjusted mortality between patients admitted
to interventional and community hospitals, despite the
differences noted in cardiac catheterization and revascu-
larization rates. Differences in adherence to acute and
long- term, guideline based medical therapies, in addition
to numerous other patient care factors not evaluated in
this study, could account for these findings. Similar find-
ings were noted in a study evaluating outcomes of
NSTEMI patients treated in academic and non-academic
centers in the United States. Despite higher utilization of
guideline based medications, cardiac catheterization and
revascularization in academic centers, there were no dif-
ferences in 1-year mortality compared to non-academic
center patients [27].
Our findings support the development of regional ini-
tiatives and processes of care that ensure appropriate ac-
cess to cardiac catheterization for patients with ACS.
Facilitating transfer of patients from hospitals without
cardiac catheterization capabilities to regional invasive
centers is essential for favorable outcomes in ACS. Such
a regional care model successfully exists in Southern
Alberta where management practices of non-cardiologistsin community centers encompass a strong compliance
with evidence-based, regional cardiac catheterization re-
ferral guidelines and protocols and an aggressive transfer
strategy for invasive investigation is the predominant
model of care in community centers. Performance of
catheterization within guideline recommended timeframes
for all patients is a recognized area for improvement
in this regional model. The development of formal re-
patriation processes of care to ensure availability of
catheterization facilities may help to achieve these goals.
This study has limitations. We evaluated cardiac
catheterization rates for ACS patients in a Canadian re-
gional model that may differ in structure from other
international models; nonetheless, our findings provide
insights into important ACS management concepts. Al-
though we demonstrated good clinical outcomes in pa-
tients undergoing cardiac catheterization we were unable
to determine why some patients were not referred for car-
diac catheterization or whether the treatment of conserva-
tively managed patients was optimal. Additionally, our
registry does not audit against key performance indicators
or provide detailed information regarding guideline based
medical therapies. Admission to presenting hospitals was
not randomly assigned, and consequently our results may
be confounded by other unmeasured factors. However,
these limitations are balanced by the strength of our
evaluation of a large, unselected group of real-world ACS
patients.
Conclusion
In this large, contemporary, registry-based study we de-
scribe a successful regional care model in which ACS pa-
tients first admitted to community hospitals have effective
access to cardiac catheterization despite geographic and
available services barriers. These findings support the im-
portance of regional initiatives and processes of care that
facilitate access to cardiac catheterization for ACS patients.
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